Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis.
about
Sublingual immunotherapy for asthmaSublingual immunotherapy for treating allergic conjunctivitisChoosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity doseManagement of the polyallergic patient with allergy immunotherapy: a practice-based approachSubcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental AllergyAllergen immunotherapy and allergic rhinitis: false beliefs.Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study.Updates in the treatment of ocular allergies."The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Efficacy of Sublingual Immunotherapy with Dermatophagoides farinae Extract in Monosensitized and Polysensitized Patients with Allergic Rhinitis: Clinical Observation and Analysis.Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined scoreAllergen immunotherapy for allergic respiratory diseasesSublingual allergen immunotherapy: mode of action and its relationship with the safety profile.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.Novel routes for allergen immunotherapy: safety, efficacy and mode of action.Diagnostics and new developments in the treatment of ocular allergies.Oralair(®): a causal treatment for grass pollen-induced allergic rhinoconjunctivitis.Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.Selection of patients for sublingual versus subcutaneous immunotherapy.Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.From IgE to clinical trials of allergic rhinitis.Sublingual immunotherapy for allergic rhinitis: where are we now?Allergen immunotherapy for birch pollen-allergic patients: recent advances.Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life studyAllergen immunotherapy (AIT) for the multiple-pollen sensitive patient.Multiallergen-specific immunotherapy in polysensitized patients: where are we?Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis.Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.Sensitisation patterns and association with age, gender, and clinical symptoms in children with allergic rhinitis in primary care: a cross-sectional study.Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects.Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation.Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases.Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation.
P2860
Q24187736-79196D04-947D-4D0E-874B-58F356B60956Q24235657-509513D8-1ABD-4A3A-94A8-0BF2EC94E4E6Q26772069-1FE0012F-050B-4901-AA97-3991BD28797FQ26772200-E27A1EC4-02EC-41E1-8D24-23671649BE04Q26852119-52C70C28-BD05-490C-AF02-74AB5E1D7B75Q28385685-2189FFA2-4CF4-4C9C-A222-6F7F8BE4E249Q33643094-C45DD79E-F5CF-47D8-9CEE-43E88FEB8AFDQ33844444-12FDAE5E-0DDC-4C2D-AC91-EB1126968CA0Q34620159-5EA2796B-22D9-429D-9245-72841980E50DQ35564301-372749E2-AB88-4D9D-84E0-A79C851A3ED0Q35591767-1B160BEB-1C7E-41F9-B4E8-326BD864C22AQ35761230-20568E10-550F-4332-B1D1-6FAF3501F0BBQ36864947-5FEC9A05-C02B-4017-9091-B6C2E3E7C632Q37965770-03AA157B-C2FA-45B8-9B10-A5A35E14A8C0Q37981739-C6EEB6FB-F703-46C4-9448-FAAA6EE19053Q37984572-C31E0BCD-F435-4AAB-9EA3-C4E9FF944E01Q37989819-575CA37B-1500-45C4-A6D3-BF8176591D36Q38068965-BF0E24E8-55CD-4A8C-81FB-03785B4DC04DQ38149941-EFE96A8A-E897-429C-9F2F-0288A1B6E411Q38247821-94F2D458-62E9-4307-B188-91968104A34DQ38257644-2DDE8A77-DEAD-4433-9ABB-C0312BDD78E8Q38271427-4E7614A0-F6D8-4B32-98D2-AC9176D2324DQ38584348-8B52F269-8BC9-4BC0-95FD-40BBFFFD1DF5Q38617692-AA53BF86-B7D1-41EB-8E7E-1A226EA24CAFQ38824177-297E999F-F0A0-44E1-97DA-3E3548636D37Q38845293-0BB2473D-1B18-4C10-9292-E6E8EF2CB58DQ38968310-37B73551-D6AE-4E93-854A-68D5201CC043Q39466603-4D8B9C4F-59E9-48FA-96F1-5EB220BE5C14Q39852307-25C1290E-67DA-489F-9998-19209C6353A9Q42944055-42312435-E467-41EF-948A-6F20273D2653Q46066121-9A3C8BF0-5826-4063-8E9D-3D40D97879A3Q46497313-85CC1AA4-B76A-4382-A469-326C63E61E49Q50222376-2130113E-B209-44D9-B0FF-2B69BD473789Q51702501-23020B85-2D3F-4A93-B0CE-AF5D78EE2BF5Q55278036-AFF43628-D0A4-41B0-8F41-0C16A2FD49A8
P2860
Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@ast
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@en
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@nl
type
label
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@ast
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@en
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@nl
prefLabel
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@ast
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@en
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@nl
P2093
P2860
P921
P1476
Efficacy and safety of 5-grass ...... allergic rhinoconjunctivitis.
@en
P2093
A Montagut
E Seberova
G Patriarca
H-J Malling
P2860
P304
P356
10.1111/J.1365-2222.2008.03152.X
P577
2008-12-24T00:00:00Z